The Priority of Non-HDL-C Assessment to Predict New Lesions among Stable Angina Patients with Strong Statins

CONCLUSIONS: Non-HDL-C ≥ 100 mg/dL was determined to be the independent risk factor for the occurrence of new lesions 9 months and ≤ 2 years after PCI among stable angina patients with strong statins. Residual risk after PCI should be considered by assessing not only DM but also non-HDL-C beyond the scope of LDL-C-lowering therapy with strong statins.PMID:34039817 | DOI:10.5551/jat.62908

Source: Journal of Atherosclerosis and Thrombosis - May 27, 2021 Category: Cardiology Authors: Daisuke Kanda Masaaki Miyata Yoshiyuki Ikeda Akihiro Tokushige Takeshi Sonoda Ryo Arikawa Kazuhiro Anzaki Ippei Kosedo Satoshi Yoshino Takuro Takumi Mitsuru Ohish Source Type: research